https://thepharmadata.com/lillys-tirzepatide-reduces-osa-severity-resolves-disease-in-51-5-of-participants/ 2024-06-22T10:13:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Lillys-Tirzepatide-Reduces-OSA-Severity-Resolves-Disease-in-51.5-of-Participants-1.webp https://thepharmadata.com/audrey-duval-derveloy-named-global-head-of-corporate-affairs-joins-sanofi-executive-committee/ 2024-06-22T10:23:00+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Audrey-Duval-Derveloy-Named-Global-Head-of-Corporate-Affairs-Joins-Sanofi-Executive-Committee.webp https://thepharmadata.com/ema-validates-bristol-myers-squibbs-subcutaneous-nivolumab-application/ 2024-06-24T10:17:16+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Application.webp https://thepharmadata.com/bristol-myers-squibb-announces-fda-accelerated-approval-of-krazati-for-kras-g12c-mutated-colorectal-cancer/ 2024-06-24T10:22:57+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Announces-2.webp https://thepharmadata.com/isth-sanofi-strengthens-hemophilia-leadership-with-new-data-on-altuviiio-and-fitusiran/ 2024-06-24T10:32:54+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/New-Data.webp https://thepharmadata.com/takeda-unveils-promising-phase-2b-mezagitamab-data-for-primary-immune-thrombocytopenia/ 2024-06-24T10:49:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Takeda-Unveils-Promising-Phase-2b-Mezagitamab-Data-for-Primary-Immune-Thrombocytopenia.webp https://thepharmadata.com/eu-approves-takedas-fruzaqla-for-treated-metastatic-colorectal-cancer/ 2024-06-24T10:56:05+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/EU-Approves-Takedas-FRUZAQLA-for-Treated-Metastatic-Colorectal-Cancer.webp https://thepharmadata.com/launch-of-berlin-center-for-gene-and-cell-therapies-in-the-capital/ 2024-06-24T11:03:19+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Launch-of-Berlin-Center-for-Gene-and-Cell-Therapies-in-the-Capital.webp https://thepharmadata.com/argenx-gets-fda-nod-for-vyvgart-with-enhanze-for-chronic-inflammatory-demyelinating-polyneuropathy/ 2024-06-25T12:37:00+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/argenx-Gets-FDA-Nod-for-VYVGART®-with-ENHANZE®-for-Chronic-Inflammatory-Demyelinating-Polyneuropathy.webp https://thepharmadata.com/kenvue-unveils-first-ever-healthy-lives-mission-report/ 2024-06-26T16:15:31+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Kenvue-Unveils-First-Ever-Healthy-Lives-Mission-Report.webp https://thepharmadata.com/pqe-group-introduces-ai-and-data-analytics-division-pioneering-innovations-in-life-science/ 2024-06-26T16:19:33+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/PQE-Group-Introduces-AI-and-Data-Analytics-Division.webp https://thepharmadata.com/biostrand-and-pgxai-partner-to-develop-ai-model-for-pharmacogenomics-with-lensai/ 2024-06-26T16:34:56+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/BioStrand-and-PGxAI-Partner-to-Develop-AI-Model.webp https://thepharmadata.com/tvm-capital-healthcare-announces-35-million-investment-in-boston-oncology-arabia/ 2024-06-26T16:38:51+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/TVM-Capital-Healthcare-Announces-35-Million-Investment-in-Boston-Oncology-Arabia.webp https://thepharmadata.com/cayuga-biotech-accelerates-life-saving-hemorrhage-treatment-with-polyp-snp-complex-promising-12x-faster-coagulation/ 2024-06-26T16:48:27+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Cayuga-Biotech-Accelerates-Life-Saving-Hemorrhage-Treatment.webp https://thepharmadata.com/augustine-therapeutics-secures-eur-17-million-in-series-a-funding-to-propel-lead-candidate-into-clinical-development-for-neurological-diseases/ 2024-06-28T10:09:10+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Neurological-Diseases.webp https://thepharmadata.com/linear-health-sciences-reports-clinical-commercial-milestones/ 2024-06-26T17:39:07+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Linear-Health-Sciences-Reports-Clinical-Commercial-Milestones.webp https://thepharmadata.com/abbvie-completes-acquisition-of-celsius-therapeutics/ 2024-06-29T10:36:24+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/AbbVie-Completes-Acquisition-of-Celsius-Therapeutics.webp https://thepharmadata.com/introducing-alle-payment-plans-powered-by-cherry/ 2024-06-29T10:40:28+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Introducing-Alle-Payment-Plans-Powered-by-Cherry.webp https://thepharmadata.com/merck-gains-positive-eu-chmp-opinion-for-winrevair-sotatercept-in-treating-pulmonary-arterial-hypertension-pah/ 2024-06-29T10:46:15+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Merck-Gains-Positive-EU-CHMP-Opinion-for-WINREVAIR™-Sotatercept-in-Treating-Pulmonary-Arterial-Hypertension-PAH.webp https://thepharmadata.com/cdc-recommends-mercks-21-valent-pneumococcal-vaccine-for-adults/ 2024-07-02T10:13:11+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/CDC-Recommends-Mercks-21-Valent-Pneumococcal-Vaccine-for-Adults.webp https://thepharmadata.com/roches-vabysmo-receives-chmp-recommendation-for-third-indication-retinal-vein-occlusion-rvo/ 2024-06-29T11:05:55+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Recommendation.webp https://thepharmadata.com/eu-approval-recommended-for-roches-piasky-in-pnh-treatment/ 2024-06-29T11:09:02+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/EU-Approval-Recommended-for-Roches-PiaSky-in-PNH-Treatment.webp https://thepharmadata.com/pfizer-and-biontech-granted-favorable-chmp-opinion-for-omicron-jn-1-adapted-covid-19-vaccine-in-the-european-union/ 2024-06-29T11:21:59+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Vaccine.webp https://thepharmadata.com/frexalimab-phase-2-results-reduction-of-key-biomarker-of-nerve-cell-damage-in-relapsing-ms/ 2024-06-29T11:26:28+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Frexalimab-Phase-2-Results-Reduction-of-Key-Biomarker-of-Nerve-Cell-Damage-in-Relapsing-MS.webp https://thepharmadata.com/leqembi-lecanemab-launches-in-china-for-alzheimers-disease-treatment/ 2024-06-29T11:32:08+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/LEQEMBI®-Lecanemab-Launches-in-China-for-Alzheimers-Disease-Treatment.webp https://thepharmadata.com/pfizer-biontech-get-chmp-nod-for-omicron-jn-1-adapted-covid-19-vaccine-in-eu/ 2024-06-29T11:40:06+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Pfizer-BioNTech-Get-CHMP-Nod-for-Omicron-JN.1-adapted-COVID-19-Vaccine-in-EU.webp https://thepharmadata.com/ucb-showcases-latest-insights-on-newly-launched-gmg-portfolio-at-ean-congress/ 2024-06-29T11:47:09+05:30 https://thepharmadata.com/wp-content/uploads/2024/06/Portfolio.webp https://thepharmadata.com/merck-announces-second-quarter-2024-sales-and-earnings-conference-call-on-july-30/ 2024-07-02T10:25:16+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Merck-Announces-Second-Quarter-2024.webp https://thepharmadata.com/merck-secures-global-rights-to-opevesostat-for-prostate-cancer/ 2024-07-02T10:29:46+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Merck-Secures-Global-Rights-to-Opevesostat-for-Prostate-Cancer.webp https://thepharmadata.com/robert-a-michael-appointed-as-ceo-of-abbvie/ 2024-07-02T10:34:56+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Robert-A.-Michael-Appointed-as-CEO-of-AbbVie.webp https://thepharmadata.com/sipavibart-ema-regulatory-submission-approved-for-accelerated-assessment-in-covid-19-prevention/ 2024-07-02T10:43:19+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Sipavibart-EMA-Regulatory-Submission-Approved.webp https://thepharmadata.com/eu-chmp-recommends-lynparza-and-imfinzi-combo-for-advanced-recurrent-endometrial-cancer/ 2024-07-02T10:50:39+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/EU-CHMP-Recommends-Lynparza-and-Imfinzi-Combo-for-AdvancedRecurrent-Endometrial-Cancer.webp https://thepharmadata.com/32-athletes-from-bayer-sports-clubs-head-to-the-summer-games-in-paris/ 2024-07-02T11:01:55+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/32-Athletes-from-Bayer-Sports-Clubs-Head-to-the-Summer-Games-in-Paris.webp https://thepharmadata.com/brenus-pharma-takes-home-french-tech-saint-etienne-lyons-prestigious-start-up-of-the-year-prize/ 2024-07-04T15:12:02+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Brenus-Pharma-Takes-Home-French-Tech-Saint-Etienne-Lyons-Prestigious-Start-up-of-the-Year-Prize.webp https://thepharmadata.com/owkin-leading-ai-biotech-innovator-expands-cutting-edge-ai-to-germany-austria-and-switzerland-to-advance-research/ 2024-07-04T15:19:49+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/AI-Biotech-Innovator.webp https://thepharmadata.com/leadershipleadership-transition-at-benevolentai/ 2024-07-04T15:30:11+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Leadership-Transition-at-BenevolentAI.webp https://thepharmadata.com/genentech-updates-phase-ii-iii-skyscraper-06-study-in-advanced-non-squamous-non-small-cell-lung-cancer/ 2024-07-04T15:41:02+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Non-Small-Cell-Lung-Cancer.webp https://thepharmadata.com/2024-antibiotic-collaboration-trends-133-deals-by-top-life-science-companies-since-2016/ 2024-07-04T16:05:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/2024-Antibiotic-Collaboration-Trends-133-Deals-by-Top-Life-Science-Companies-Since-2016.webp https://thepharmadata.com/brenus-pharma-receives-the-big-start-up-of-the-year-award-from-french-tech-saint-etienne-lyon/ 2024-07-04T16:13:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Brenus-Pharma-Receives-the-BIG-Start-up-of-the-Year-Award-from-French-Tech-Saint-Etienne-Lyon.webp https://thepharmadata.com/owkin-an-ai-biotech-unicorn-expands-to-germany-austria-and-switzerland-to-accelerate-research-with-cutting-edge-ai/ 2024-07-04T16:21:32+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Owkin-an-AI-Biotech-Unicorn-Expands-to-Germany-Austria-and-Switzerland-to-Accelerate-Research-with-Cutting-Edge-AI.webp https://thepharmadata.com/unprecedented-opportunities-265-collaborative-and-licensing-deals-in-in-vitro-diagnostics/ 2024-07-04T16:32:42+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Unprecedented-Opportunities-265-Collaborative-and-Licensing-Deals-in-In-Vitro-Diagnostics.webp https://thepharmadata.com/genexine-and-epd-biotherapeutics-merge-to-enhance-drug-development-pipeline/ 2024-07-04T16:42:15+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Genexine-and-EPD-Biotherapeutics-Merge-to-Enhance-Drug-Development-Pipeline.webp https://thepharmadata.com/navidea-biopharmaceuticals-inc-releases-findings-from-exploratory-analysis-conducted-on-july-2-2024/ 2024-07-06T10:11:48+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Analysis-Conducted.webp https://thepharmadata.com/fda-approves-roches-vabysmo-prefilled-syringe-for-three-major-causes-of-vision-loss/ 2024-07-06T10:08:33+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/FDA-Approves-Roches-Vabysmo-Prefilled-Syringe-for-Three-Major-Causes-of-Vision-Loss.webp https://thepharmadata.com/nominations-now-open-for-the-prestigious-2024-tu-youyou-award/ 2024-07-06T10:18:36+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Nominations-Now-Open-for-the-Prestigious-2024-Tu-Youyou-Award.webp https://thepharmadata.com/cencora-sets-date-and-time-for-q3-fiscal-2024-earnings-release/ 2024-07-06T10:22:11+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Cencora-Sets-Date-and-Time-for-Q3-Fiscal-2024-Earnings-Release.webp https://thepharmadata.com/calidi-to-effect-reverse-stock-split/ 2024-07-06T10:31:48+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Calidi-to-Effect-Reverse-Stock-Split.webp https://thepharmadata.com/2019-2024-pharma-collaboration-report-upfront-milestones-royalties-by-company-therapy-tech-researchandmarkets-com/ 2024-07-06T10:38:10+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/2019-2024-Pharma-Collaboration-Report-Upfront-Milestones-Royalties-by-Company-Therapy.webp https://thepharmadata.com/global-hospital-care-partnering-deals-analysis-2016-2024-collaboration-development-and-licensing-by-company-deal-type-and-therapy-area/ 2024-07-06T10:45:49+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Hospital-Care-2.webp https://thepharmadata.com/correction-and-update-axena-health-secures-two-more-favorable-insurance-coverage-approvals-for-leva/ 2024-07-06T10:48:56+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Correction-and-Update-Axena-Health-Secures-Two-More-Favorable-Insurance-Coverage-Approvals-for-Leva.webp https://thepharmadata.com/neuranics-wins-deep-tech-investment-of-the-year-award-at-the-angel-investment-awards/ 2024-07-06T10:52:29+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Neuranics-Wins-Deep-Tech-Investment-of-the-Year-Award-at-the-Angel-Investment-Awards.webp https://thepharmadata.com/global-sanitation-summit-hosted-by-who-unicef-and-wateraid/ 2024-07-06T10:58:28+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Global-Sanitation-Summit-Hosted-by-WHO-UNICEF-and-WaterAid.webp https://thepharmadata.com/analysis-of-influenza-cases-reported-over-the-last-two-months/ 2024-07-06T11:02:13+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Analysis-of-Influenza-Cases-Reported-Over-the-Last-Two-Months.webp https://thepharmadata.com/who-marks-milestone-in-influenza-preparedness-in-south-east-asia/ 2024-07-06T11:05:40+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/WHO-Marks-Milestone-in-Influenza-Preparedness-in-South-East-Asia.webp https://thepharmadata.com/commending-ten-years-of-the-severe-acute-respiratory-infections-network-in-the-americas/ 2024-07-06T11:09:43+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Commending-Ten-Years-of-the-Severe-Acute-Respiratory-Infections-Network-in-the-Americas.webp https://thepharmadata.com/epsilogen-receives-cta-approval-for-phase-ib-trial-of-mov18-ige-in-platinum-resistant-ovarian-cancer/ 2024-07-10T16:16:28+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Epsilogen-Receives-CTA-Approval-for-Phase-Ib-Trial-of-MOv18-IgE-in-Platinum-Resistant-Ovarian-Cancer.webp https://thepharmadata.com/adicet-bio-secures-fda-fast-track-designation-for-adi-270-in-advanced-metastatic-clear-cell-renal-cell-carcinoma/ 2024-07-10T16:21:59+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Adicet-Bio-Secures-FDA-Fast-Track-Designation-for-ADI-270-in-Advanced-Metastatic-Clear-Cell-Renal-Cell.webp https://thepharmadata.com/ligand-to-acquire-apeiron-biologics-ag-in-a-100-million-deal/ 2024-07-10T16:27:51+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Ligand-to-Acquire-APEIRON-Biologics-AG-in-a-100-Million-Deal.webp https://thepharmadata.com/xeris-biopharma-unveils-new-ceo-succession-strategy/ 2024-07-10T16:33:53+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Xeris-Biopharma-Unveils-New-CEO-Succession-Strategy.webp https://thepharmadata.com/harrow-signs-340b-prime-vendor-contract-with-apexus-for-iheezo-and-key-products/ 2024-07-10T16:49:13+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Harrow-Signs-340B-Prime-Vendor-Contract-with-Apexus™-for-IHEEZO®-and-Key-Products.webp https://thepharmadata.com/precision-neuromodulation-reduces-brain-atrophy-and-boosts-connectivity-in-alzheimers-patients/ 2024-07-10T17:27:38+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Precision-Neuromodulation-Reduces-Brain-Atrophy-and-Boosts-Connectivity-in-Alzheimers-Patients.webp https://thepharmadata.com/cytotronics-advances-live-cell-monitoring-and-introduces-pixel-octo-for-high-throughput-cell-biology-discovery/ 2024-07-10T17:08:19+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Cell-Biology.webp https://thepharmadata.com/nice-recommends-ebglyss-for-moderate-to-severe-atopic-dermatitis-treatment-in-nhs-england-for-eligible-adolescents-and-adults/ 2024-07-10T17:17:09+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Treatment-4.webp https://thepharmadata.com/daiichi-sankyo-launches-new-oncology-affiliate-in-greece/ 2024-07-10T17:26:33+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Daiichi-Sankyo-Launches-New-Oncology-Affiliate-in-Greece-2.webp https://thepharmadata.com/abbvie-seeks-fda-and-ema-approval-for-upadacitinib-rinvoq-to-treat-giant-cell-arteritis/ 2024-07-13T09:53:59+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/AbbVie-Seeks-FDA-and-EMA-Approval-for-Upadacitinib-RINVOQ®-to-Treat-Giant-Cell-Arteritis.webp https://thepharmadata.com/un-joint-statement-advocating-for-universal-sexual-and-reproductive-health-and-rights/ 2024-07-13T10:19:38+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/UN-Joint-Statement-Advocating-for-Universal-Sexual-and-Reproductive-Health-and-Rights.webp https://thepharmadata.com/who-introduces-innovative-training-course-to-empower-parliamentarians-in-global-health-security/ 2024-07-13T10:26:20+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/WHO-Introduces-Innovative-Training-Course-to-Empower-Parliamentarians-in-Global-Health-Security.webp https://thepharmadata.com/lupin-limited-receives-eir-from-u-s-fda-for-dabhasa-facility/ 2024-07-13T10:30:57+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Lupin-Limited-Receives-EIR-from-U.S.-FDA-for-Dabhasa-Facility.webp https://thepharmadata.com/lupin-secures-u-s-fda-approval-for-topiramate-extended-release-capsules/ 2024-07-13T10:34:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Lupin-Secures-U.S.-FDA-Approval-for-Topiramate-Extended-Release-Capsules.webp https://thepharmadata.com/rason-inhibitors-show-strong-anti-tumor-activity-in-preclinical-models-of-refractory-kras-mutated-non-small-cell-lung-cancer/ 2024-07-13T10:44:12+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/RASON-Inhibitors-Show-Strong-Anti-Tumor-Activity-in-Preclinical-Models-of-Refractory-KRAS-Mutated-Non-Small-Cell-Lung-Cancer.webp https://thepharmadata.com/zura-bio-initiates-warrant-exchange-offer-and-seeks-consent/ 2024-07-13T10:50:33+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Zura-Bio-Initiates-Warrant-Exchange-Offer-and-Seeks-Consent.webp https://thepharmadata.com/roche-announces-positive-phase-i-results-for-obesity-treatment-ct-996/ 2024-07-20T10:14:40+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Roche-Announces-Positive-Phase-I-Results-for-Obesity-Treatment-CT-996.webp https://thepharmadata.com/roches-vabysmo-proves-durable-and-effective-in-long-term-dme-study/ 2024-07-20T10:22:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/DME-Study.webp https://thepharmadata.com/new-data-shows-sustained-efficacy-of-roches-susvimo-in-two-serious-diabetic-eye-conditions/ 2024-07-20T10:29:27+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/New-Data-Shows-Sustained-Efficacy-of-Roches-Susvimo-in-Two-Serious-Diabetic-Eye-Conditions.webp https://thepharmadata.com/bristol-myers-squibb-achieves-significant-environmental-sustainability-milestone/ 2024-07-20T10:42:39+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Bristol-Myers-Squibb-Achieves-Significant-Environmental-Sustainability-Milestone.webp https://thepharmadata.com/ema-validates-bristol-myers-opdivo-yervoy-for-advanced-liver-cancer/ 2024-07-20T10:52:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/EMA-Validates-Bristol-Myers-Opdivo-Yervoy-for-Advanced-Liver-Cancer.webp https://thepharmadata.com/merck-launches-first-gmp-compliant-cell-culture-media-production-line-in-china/ 2024-07-20T11:01:35+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Merck-Launches-First-GMP-Compliant-Cell-Culture-Media-Production-Line-in-China.webp https://thepharmadata.com/merck-to-acquire-unity-sc-enhancing-ai-enabled-semiconductor-solutions/ 2024-07-20T11:16:43+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Semiconductor-Solutions-2.webp https://thepharmadata.com/wuxi-apptec-repeats-as-ftse4good-index-series-member/ 2024-07-20T11:24:14+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/WuXi-AppTec-Repeats-as-FTSE4Good-Index-Series-Member.webp https://thepharmadata.com/argenx-and-zai-lab-announce-efgartigimod-alfa-approval-for-myasthenia-gravis-in-china/ 2024-07-20T11:35:35+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/argenx-and-Zai-Lab-Announce-Efgartigimod-Alfa-Approval-for-Myasthenia-Gravis-in-China.webp https://thepharmadata.com/beigene-names-aaron-rosenberg-as-new-chief-financial-officer/ 2024-07-20T11:42:54+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/BeiGene-Names-Aaron-Rosenberg-as-New-Chief-Financial-Officer.webp https://thepharmadata.com/wuxi-biologics-secures-place-in-ftse4good-index-series-for-fourth-consecutive-year/ 2024-07-20T11:50:17+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Biologics.webp https://thepharmadata.com/labcorp-achieves-highest-rating-on-the-2024-disability-equality-index/ 2024-07-20T11:55:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Labcorp-Achieves-Highest-Rating-on-the-2024-Disability-Equality-Index®-1.webp https://thepharmadata.com/neurocrine-biosciences-launches-ingrezza-sprinkle-for-easier-swallowing/ 2024-07-20T12:10:34+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Neurocrine-Biosciences-Launches-INGREZZA®-SPRINKLE-for-Easier-Swallowing.webp https://thepharmadata.com/opdivo-approved-in-south-korea-for-first-line-treatment-of-unresectable-or-metastatic-urothelial-carcinoma/ 2024-07-20T12:21:31+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Opdivo®-Approved-in-South-Korea-for-First-Line-Treatment-of-Unresectable-or-Metastatic-Urothelial-Carcinoma-1.webp https://thepharmadata.com/who-updates-hiv-testing-boost-for-self-testing-integration-and-prevention/ 2024-07-20T12:39:21+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/WHO-Updates-HIV-Testing-Boost-for-Self-Testing_-Integration_-and-Prevention.webp https://thepharmadata.com/who-at-the-25th-international-aids-conference/ 2024-07-20T12:46:00+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/WHO-at-the-25th-International-AIDS-Conference_11zon.webp https://thepharmadata.com/june-2024-message-from-who-immunization-director/ 2024-07-20T12:54:36+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Immunization_11zon.jpg https://thepharmadata.com/ionis-finishes-enrollment-in-key-trial-assessing-zilganersen-for-alexander-disease/ 2024-07-20T13:09:29+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Ionis-Finishes-Enrollment-in-Key-Trial-Assessing-Zilganersen-for-Alexander-Disease_11zon.webp https://thepharmadata.com/rusan-pharmas-ankleshwar-api-plant-receives-usfda-gmp-approval/ 2024-07-22T17:20:23+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Rusan-Pharmas-Ankleshwar-API-Plant-Receives-USFDA-GMP-Approval_11zon.webp https://thepharmadata.com/ahf-press-conference-advocates-urge-gilead-to-prioritize-lives-over-profits-at-aids-2024/ 2024-07-22T17:25:30+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/AHF-Press-Conference-Advocates-Urge-Gilead-to-Prioritize-Lives-Over-Profits-at-AIDS-2024_11zon.webp https://thepharmadata.com/gilead-and-elton-john-aids-foundation-extend-radian-partnership-to-tackle-hiv-in-eastern-europe-and-central-asia/ 2024-07-22T17:28:41+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Gilead-and-Elton-John-AIDS-Foundation-Extend-RADIAN-Partnership-to-Tackle_11zon.webp https://thepharmadata.com/lario-therapeutics-receives-6m-grant-from-michael-j-fox-foundation-for-parkinsons-research/ 2024-07-22T17:32:01+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Lario-Therapeutics-Receives-6M-Grant-from-Michael-J.-Fox-Foundation-for-Parkinsons-Research.webp https://thepharmadata.com/pharmaceutical-leader-kare-schultz-appointed-to-hims-hers-board/ 2024-07-22T17:35:50+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Pharmaceutical-Leader-Kare-Schultz-Appointed-to-Hims-Hers-Board.webp https://thepharmadata.com/verastem-oncology-announces-55m-public-offering/ 2024-07-24T17:15:13+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Verastem-Oncology-Announces-55M-Public-Offering_11zon.webp https://thepharmadata.com/verastem-oncology-announces-public-offering-of-stock-and-warrants/ 2024-07-24T17:11:18+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Verastem-Oncology-Announces-Public-Offering-of-Stock-and-Warrants_11zon.jpg https://thepharmadata.com/nuvation-bio-updates-and-presentations-on-ros1-inhibitor-taletrectinib/ 2024-07-24T17:14:58+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Nuvation-Bio-Updates-and-Presentations-on-ROS1-Inhibitor-Taletrectinib_11zon.webp https://thepharmadata.com/proteina-co-announces-breakthrough-in-nature-biomedical-engineering/ 2024-07-24T17:18:53+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/PROTEINA-Co.-Announces-Breakthrough-in-Nature-Biomedical-Engineering_11zon.webp https://thepharmadata.com/pk-med-secures-e1-5m-bpifrance-funding-for-cell-homing-implant-in-bone-marrow-transplants/ 2024-07-24T17:23:40+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/PK-MED-Secures-E1.5M-Bpifrance-Funding-for-Cell-Homing-Implant-in-Bone-Marrow-Transplants.webp https://thepharmadata.com/autobahn-therapeutics-raises-100-million-in-oversubscribed-series-c-for-cns-disorder-treatments/ 2024-07-24T17:30:17+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Autobahn-Therapeutics-Raises-100-Million-in-Oversubscribed-Series-C-for-CNS-Disorder-Treatments_11zon.webp https://thepharmadata.com/merck-gets-eu-chmp-nod-for-keytruda-and-padcev-combo-in-urothelial-cancer/ 2024-07-29T10:09:22+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Merck-Gets-EU-CHMP-Nod-for-KEYTRUDA®-and-Padcev®-Combo-in-Urothelial-Cancer.webp https://thepharmadata.com/european-authority-endorses-wegovy-label-update-for-lowering-cardiovascular-risk/ 2024-07-29T10:14:01+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/European-Authority-Endorses-Wegovy®-Label-Update-for-Lowering-Cardiovascular-Risk.jpg https://thepharmadata.com/abbvie-gains-eu-approval-for-skyrizi-to-treat-ulcerative-colitis/ 2024-07-29T10:20:38+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/AbbVie-Gains-EU-Approval-for-SKYRIZI®-to-Treat-Ulcerative-Colitis.webp https://thepharmadata.com/abbvie-announces-financial-results-for-q2-2024/ 2024-07-29T10:26:25+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/AbbVie-Announces-Financial-Results-for-Q2-2024_11zon.webp https://thepharmadata.com/roche-acquires-lumiradxs-point-of-care-tech-to-boost-primary-care-diagnostics/ 2024-07-31T10:08:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Roche-Acquires-LumiraDxs-Point-of-Care-Tech-to-Boost-Primary-Care-Diagnostics_11zon.webp https://thepharmadata.com/european-commission-approves-roches-vabysmo-for-retinal-vein-occlusion-rvo-treatment/ 2024-07-31T10:12:43+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/European-Commission-Approves-Roches-Vabysmo-for-Retinal-Vein-Occlusion-RVO-Treatment_11zon.webp https://thepharmadata.com/allergan-aesthetics-celebrates-second-annual-juvederm-day/ 2024-07-31T10:21:51+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Allergan-Aesthetics-Celebrates-Second-Annual-JUVEDERM®-Day.webp https://thepharmadata.com/fda-grants-priority-review-to-novartis-scemblix-for-newly-diagnosed-cml/ 2024-07-31T10:26:04+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/FDA-Grants-Priority-Review-to-Novartis-Scemblix®-for-Newly-Diagnosed-CML.webp https://thepharmadata.com/amplify-phase-iii-trial-fixed-duration-calquence-and-venetoclax-%c2%b1-obinutuzumab-boosts-pfs-in-1st-line-cll/ 2024-07-31T10:31:01+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/AMPLIFY-Phase-III-Trial-Fixed-Duration-Calquence-and-Venetoclax-±-Obinutuzumab-Boosts-PFS-in-1st-Line-CLL.webp https://thepharmadata.com/vertex-announces-fda-acceptance-of-suzetrigine-nda-for-acute-pain/ 2024-07-31T10:39:21+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Vertex-Announces-FDA-Acceptance-of-Suzetrigine-NDA-for-Acute-Pain_11zon.webp https://thepharmadata.com/biogen-beckman-coulter-and-fujirebio-collaborate-on-blood-test-for-alzheimers-tau-pathology/ 2024-07-31T10:45:53+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/Biogen-Beckman-Coulter-and-Fujirebio-Collaborate-on-Blood-Test-for-Alzheimers-Tau-Pathology.webp https://thepharmadata.com/new-data-3-years-of-leqembi-treatment-benefits-early-alzheimers-patients/ 2024-07-31T10:50:15+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/New-Data-3-Years-of-LEQEMBI®-Treatment-Benefits-Early-Alzheimers-Patients.webp https://thepharmadata.com/wuxi-apptec-reports-stable-operations-and-growth-in-q2-2024-revenue-up-16-qoq-adjusted-net-profit-up-28-5-qoq/ 2024-07-31T10:54:13+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/WuXi-AppTec-Reports-Stable-Operations-and-Growth-in-Q2-2024-Revenue-Up-16-QoQ-Adjusted-Net-Profit-Up-28.5-QoQ_11zon.webp https://thepharmadata.com/biontech-reports-promising-phase-2-results-for-mrna-immunotherapy-bnt111-in-advanced-melanoma-patients/ 2024-07-31T10:58:32+05:30 https://thepharmadata.com/wp-content/uploads/2024/07/BioNTech-Reports-Promising-Phase-2-Results-for-mRNA-Immunotherapy-BNT111-in-Advanced-Melanoma-Patients_11zon.webp https://thepharmadata.com/lillys-tirzepatide-shows-success-in-phase-3-study-for-heart-failure-and-obesity/ 2024-08-03T10:13:17+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Lillys-Tirzepatide-Shows-Success-in-Phase-3-Study-for-Heart-Failure-and-Obesity_11zon.jpg https://thepharmadata.com/abbvie-finalizes-acquisition-of-cerevel-therapeutics/ 2024-08-03T10:38:24+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/AbbVie-Finalizes-Acquisition-of-Cerevel-Therapeutics_11zon.webp https://thepharmadata.com/vertex-announces-financial-results-for-q2-2024/ 2024-08-03T11:14:39+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Vertex-Announces-Financial-Results-for-Q2-2024_11zon.webp https://thepharmadata.com/cvs-health-launches-unique-initiative-to-aid-vulnerable-patients-in-extreme-weather/ 2024-08-03T11:14:22+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/CVS-Health®-Launches-Unique-Initiative-to-Aid-Vulnerable-Patients-in-Extreme-Weather.webp https://thepharmadata.com/labcorp-reports-q2-2024-financial-results/ 2024-08-03T11:13:59+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Labcorp-Reports-Q2-2024-Financial-Results_11zon.webp https://thepharmadata.com/neurocrine-biosciences-reports-q2-2024-financial-results-and-increases-2024-ingrezza-sales-forecast/ 2024-08-03T11:37:34+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Neurocrine-Biosciences-Reports-Q2-2024-Financial-Results-and-Increases-2024-INGREZZA-Sales-Forecast_11zon-1.webp https://thepharmadata.com/puma-biotechnology-announces-financial-results-for-q2/ 2024-08-03T11:37:19+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Puma-Biotechnology-Announces-Financial-Results-for-Q2_11zon.webp https://thepharmadata.com/agilent-gains-fda-approval-for-mage-a4-ihc-1f9-pharmdx-as-a-diagnostic-tool-for-new-tcr-t-cell-therapy/ 2024-08-03T11:40:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Agilent-Gains-FDA-Approval-for-MAGE-A4-IHC-1F9-pharmDx-as-a-Diagnostic-Tool-for-New-TCR-T-Cell-Therapy_11zon.webp https://thepharmadata.com/coya-therapeutics-to-present-alzheimers-study-results-at-ctad24-in-madrid/ 2024-08-03T11:45:01+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Coya-Therapeutics-to-Present-Alzheimers-Study-Results-at-CTAD24-in-Madrid.webp https://thepharmadata.com/os-therapies-osteosarcoma-patient-advocacy-and-advisory-board/ 2024-08-03T11:48:48+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/OS-Therapies-Osteosarcoma-Patient-Advocacy-and-Advisory-Board_11zon.webp https://thepharmadata.com/amylyxs-amx0035-gets-orphan-drug-status-for-wolfram-syndrome-in-europe/ 2024-08-05T09:57:35+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Amylyxs-AMX0035-Gets-Orphan-Drug-Status-for-Wolfram-Syndrome-in-Europe_11zon.webp https://thepharmadata.com/bioaffinity-technologies-sets-pricing-for-1-75m-direct-offering-private-placement-and-warrant-inducement/ 2024-08-03T11:58:11+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/bioAffinity-Technologies-Sets-Pricing-for-1.75M-Direct-Offering-Private-Placement-and-Warrant-Inducement_11zon.webp https://thepharmadata.com/u-s-oligonucleotide-synthesis-market-report-2024-2030-trends-shares-and-analysis/ 2024-08-03T12:03:07+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/U.S.-Oligonucleotide-Synthesis-Market-Report-2024-2030-Trends-Shares-and-Analysis_11zon.webp https://thepharmadata.com/bayer-achieves-primary-endpoint-in-phase-iii-finearts-hf-study-of-kerendia-for-heart-failure/ 2024-08-06T10:59:03+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Bayer-Achieves-Primary-Endpoint-in-Phase-III-FINEARTS-HF-Study-of-KERENDIA®-for-Heart-Failure.webp https://thepharmadata.com/salubris-biotherapeutics-receives-ema-approval-to-launch-phase-1-clinical-trial-of-5t4-targeted-adc-jk06-in-solid-tumors/ 2024-08-06T11:02:46+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Salubris-Biotherapeutics-Receives-EMA-Approval-to-Launch-Phase-1-Clinical-Trial-of-5T4-Targeted-ADC-JK06-in-Solid-Tumors_11zon.jpg https://thepharmadata.com/imbrium-therapeutics-submits-new-drug-application-to-investigate-sunobinop-for-alcohol-use-disorder-treatment/ 2024-08-06T11:08:21+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Imbrium-Therapeutics-Submits-New-Drug-Application-to-Investigate-Sunobinop-for-Alcohol-Use-Disorder-Treatment_11zon.webp https://thepharmadata.com/iliad-biotechnologies-named-to-fierce-biotechs-2024-fierce-15/ 2024-08-06T11:12:49+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/ILiAD-Biotechnologies-Named-to-Fierce-Biotechs-2024-Fierce-15_11zon.webp https://thepharmadata.com/alzamend-neuro-and-mass-general-launch-phase-ii-trial-of-al001-for-alzheimers/ 2024-08-10T10:21:49+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Alzamend-Neuro-and-Mass-General-Launch-Phase-II-Trial-of-AL001-for-Alzheimers_11zon.webp https://thepharmadata.com/professional-pickleball-player-james-ignatowich-teams-up-with-ibsa-usa-to-advocate-for-licart/ 2024-08-06T11:22:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Professional-Pickleball-Player-James-Ignatowich-Teams-Up-with-IBSA-USA-to-Advocate-for-Licart_11zon.webp https://thepharmadata.com/rite-aid-now-offering-flu-and-rsv-vaccine-appointments-at-all-locations/ 2024-08-06T11:25:17+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Rite-Aid-Now-Offering-Flu-and-RSV-Vaccine-Appointments-at-All-Locations_11zon.webp https://thepharmadata.com/novo-nordisks-sales-up-24-to-dkk-133-4-billion-in-first-half-of-2024/ 2024-08-10T10:18:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Novo-Nordisks-Sales-Up-24-to-DKK-133.4-Billion-in-First-Half-of-2024_11zon.webp https://thepharmadata.com/lilly-q2-2024-financial-results-3b-revenue-guidance-boost/ 2024-08-10T10:15:00+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Lilly-Q2-2024-Financial-Results-3B-Revenue-Guidance-Boost_11zon_11zon.webp https://thepharmadata.com/novartis-wins-fda-approval-for-fabhalta-first-complement-inhibitor-for-igan/ 2024-08-10T10:25:37+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Novartis-Wins-FDA-Approval-for-Fabhalta®-First-Complement-Inhibitor-for-IgAN.webp https://thepharmadata.com/sarclisa-induction-boosts-progression-free-survival-in-transplant-eligible-multiple-myeloma/ 2024-08-10T10:34:04+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Sarclisa-Induction-Boosts-Progression-Free-Survival-in-Transplant-Eligible-Multiple-Myeloma_11zon.webp https://thepharmadata.com/vertex-secures-casgevy-reimbursement-for-beta-thalassemia-in-england/ 2024-08-10T10:40:18+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Vertex-Secures-CASGEVY™-Reimbursement-for-Beta-Thalassemia-in-England-2.webp https://thepharmadata.com/takeda-gets-ec-approval-for-adzynma-first-recombinant-adamts13-therapy-for-cttp/ 2024-08-10T10:49:25+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Takeda-Gets-EC-Approval-for-ADZYNMA®-First-Recombinant-ADAMTS13-Therapy-for-cTTP.webp https://thepharmadata.com/royalty-pharma-announces-second-quarter-2024-financial-results/ 2024-08-10T12:57:15+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Royalty-Pharma-Announces-Second-Quarter-2024-Financial-Results_11zon.webp https://thepharmadata.com/wuxi-biologics-and-medigene-team-up-for-tcr-guided-t-cell-engager-research/ 2024-08-10T11:13:09+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/WuXi-Biologics-and-Medigene-Team-Up-for-TCR-Guided-T-Cell-Engager-Research_11zon.webp https://thepharmadata.com/bio-techne-reports-fiscal-q4-2024-financial-results/ 2024-08-10T11:17:02+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Bio-Techne-Reports-Fiscal-Q4-2024-Financial-Results_11zon.webp https://thepharmadata.com/hansoh-pharma-and-lupeng-pharma-reveal-licensing-deal-for-lp-168/ 2024-08-10T11:22:16+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Hansoh-Pharma-and-Lupeng-Pharma-Reveal-Licensing-Deal-for-LP-168_11zon.webp https://thepharmadata.com/legend-biotech-announces-q2-2024-financial-results-and-key-developments/ 2024-08-10T11:33:36+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Legend-Biotech-Announces-Q2-2024-Financial-Results-and-Key-Developments_11zon.webp https://thepharmadata.com/sarepta-therapeutics-q2-2024-financial-results-and-updates/ 2024-08-10T12:56:38+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Sarepta-Therapeutics-Q2-2024-Financial-Results-and-Updates_11zon.webp https://thepharmadata.com/china-approves-enhertu-for-treated-her2-advanced-gastric-cancer/ 2024-08-14T09:58:15+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/China-Approves-Enhertu-for-Treated-HER2-Advanced-Gastric-Cancer_11zon.webp https://thepharmadata.com/scholar-rock-reports-new-employee-inducement-awards-under-nasdaq-listing-rule-5635c4/ 2024-08-17T10:37:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Scholar-Rock-Reports-New-Employee-Inducement-Awards-Under-Nasdaq-Listing-Rule-5635c4-scaled.webp https://thepharmadata.com/agendia-ottiene-la-certificazione-ce-ivdr-per-i-test-mammaprint-e-blueprint-sul-cancro-al-seno/ 2024-08-17T10:51:07+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Agendia-Ottiene-la-Certificazione-CE-IVDR-per-i-Test-MammaPrint®-e-BluePrint®-sul-Cancro-al-Seno.webp https://thepharmadata.com/audax-private-equity-to-acquire-avantors-clinical-services-division/ 2024-08-17T10:50:17+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Audax-Private-Equity-to-Acquire-Avantors-Clinical-Services-Division.webp https://thepharmadata.com/pfizer-and-biontech-announce-update-on-mrna-combination-vaccine-program-for-influenza-and-covid-19-in-adults-aged-18-64/ 2024-08-17T10:57:44+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Pfizer-and-BioNTech-Announce-Update-on-mRNA-Combination-Vaccine-Program-for-Influenza-and-COVID-19-in-Adults-Aged-18-64-2.webp https://thepharmadata.com/incyte-announces-positive-topline-results-from-pivotal-study-of-tafasitamab-monjuvi-in-relapsed-or-refractory-follicular-lymphoma/ 2024-08-17T11:03:53+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Incyte-Announces-Positive-Topline-Results-from-Pivotal-Study-of-Tafasitamab-Monjuvi®-in-Relapsed-or-Refractory-Follicular-Lymphoma.webp https://thepharmadata.com/agendia-receives-ce-ivdr-certification-for-mammaprint-and-blueprint-breast-cancer-assays/ 2024-08-17T11:10:50+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Agendia-Receives-CE-IVDR-Certification-for-MammaPrint®-and-BluePrint®-Breast-Cancer-Assays.webp https://thepharmadata.com/imfinzi-durvalumab-gains-us-approval-for-pre-and-post-surgery-treatment-of-resectable-non-small-cell-lung-cancer/ 2024-08-17T11:16:32+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/IMFINZI®-durvalumab-Gains-US-Approval-for-Pre-and-Post-Surgery-Treatment-of-Resectable-Non-Small-Cell-Lung-Cancer.webp https://thepharmadata.com/an2-therapeutics-implements-limited-term-shareholder-rights-plan/ 2024-08-17T11:21:02+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/AN2-Therapeutics-Implements-Limited-Term-Shareholder-Rights-Plan.webp https://thepharmadata.com/amorsui-secures-3-5m-seed-funding-to-transform-sustainable-medical-supplies/ 2024-08-17T11:27:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/AmorSui-Secures-3.5M-Seed-Funding-to-Transform-Sustainable-Medical-Supplies.webp https://thepharmadata.com/daiwa-health-development-inc-to-host-webinar-with-dr-fred-pescatore-on-clinical-applications-of-rbac/ 2024-08-17T12:27:51+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Daiwa-Health-Development-Inc.-to-Host-Webinar-with-Dr.-Fred-Pescatore-on-Clinical-Applications-of-RBAC.webp https://thepharmadata.com/uptimehealth-and-darby-dental-supply-collaborate-to-introduce-darby-dispatch-a-new-solution-for-improving-efficiency-and-compliance-in-dental-practices-across-the-country/ 2024-08-17T12:32:39+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/UptimeHealth-and-Darby-Dental-Supply-Collaborate-to-Introduce-Darby-Dispatch-A-New-Solution-for-Improving-Efficiency-and-Compliance-in-Dental-Practices-Across-the-Country.webp https://thepharmadata.com/medea-inc-teams-up-with-caloptima-health-to-distribute-100000-naloxone-units-to-southern-california-harm-reduction-groups/ 2024-08-17T12:36:37+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Medea-Inc.-Teams-Up-with-CalOptima-Health-to-Distribute-100000-Naloxone-Units-to-Southern-California-Harm-Reduction-Groups.webp https://thepharmadata.com/tirzepatide-cuts-type-2-diabetes-risk-by-94-in-adults-with-pre-diabetes-and-obesity-or-overweight/ 2024-08-21T17:34:14+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Tirzepatide-Cuts-Type-2-Diabetes-Risk-by-94-in-Adults-with-Pre-Diabetes-and-Obesity-or-Overweight.webp https://thepharmadata.com/eu-approves-second-indication-for-tepkinly-in-treating-relapsed-refractory-follicular-lymphoma/ 2024-08-21T17:46:15+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/EU-Approves-Second-Indication-for-TEPKINLY-in-Treating-RelapsedRefractory-Follicular-Lymphoma.webp https://thepharmadata.com/roche-addresses-whos-global-health-emergency-declaration-amid-ongoing-mpox-outbreak/ 2024-08-21T18:00:17+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Roche-Addresses-WHOs-Global-Health-Emergency-Declaration-Amid-Ongoing-Mpox-Outbreak.webp https://thepharmadata.com/otezla-apremilast-now-available-in-the-u-s-for-moderate-to-severe-pediatric-plaque-psoriasis-treatment/ 2024-08-22T09:57:04+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/OTEZLA®-Apremilast-Now-Available-in-the-U.S.-for-Moderate-to-Severe-Pediatric-Plaque-Psoriasis-Treatment.webp https://thepharmadata.com/bristol-myers-squibbs-sbla-accepted-by-fda-for-first-line-treatment-of-unresectable-hepatocellular-carcinoma/ 2024-08-22T12:52:10+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Bristol-Myers-Squibbs-sBLA-Accepted-by-FDA-for-First-Line-Treatment-of-Unresectable-Hepatocellular-Carcinoma.webp https://thepharmadata.com/lupin-gains-health-canada-approval-for-pegfilgrastim-biosimilar/ 2024-08-24T10:02:54+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Lupin-Gains-Health-Canada-Approval-for-Pegfilgrastim-Biosimilar.webp https://thepharmadata.com/elanco-animal-health-to-expand-production-capabilities-at-kansas-manufacturing-facility/ 2024-08-24T10:11:06+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Elanco-Animal-Health-to-Expand-Production-Capabilities-at-Kansas-Manufacturing-Facility.webp https://thepharmadata.com/jazz-pharmaceuticals-updates-on-phase-3-trial-of-cannabidiol-for-epilepsy-in-japan/ 2024-08-24T10:19:32+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/pexels-kindelmedia-7667731.jpg https://thepharmadata.com/viatris-unveils-late-breaking-abstract-on-cenerimod-at-the-26th-aplar-annual-congress/ 2024-08-24T10:31:04+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Viatris-Unveils-Late-Breaking-Abstract-on-Cenerimod-at-the-26th-APLAR-Annual-Congress.webp https://thepharmadata.com/wuxi-biologics-announces-strong-interim-results-for-2024/ 2024-08-24T10:38:26+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/WuXi-Biologics-Announces-Strong-Interim-Results-for-2024.webp https://thepharmadata.com/biomarin-appoints-new-leaders-in-rd-and-business-development/ 2024-08-24T10:43:34+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/BioMarin-Appoints-New-Leaders-in-RD-and-Business-Development.webp https://thepharmadata.com/tepkinly-epcoritamab-gets-second-european-approval-for-relapsed-refractory-follicular-lymphoma/ 2024-08-24T10:49:56+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/TEPKINLY®-epcoritamab-Gets-Second-European-Approval-for-RelapsedRefractory-Follicular-Lymphoma.webp https://thepharmadata.com/china-approves-padcev-for-advanced-urothelial-cancer/ 2024-08-24T10:58:27+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/China-Approves-PADCEV™-for-Advanced-Urothelial-Cancer.webp https://thepharmadata.com/pfizer-and-biontech-get-u-s-fda-approval-for-omicron-kp-2-adapted-covid-19-vaccine/ 2024-08-24T11:05:45+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Pfizer-and-BioNTech-Get-U.S.-FDA-Approval-for-Omicron-KP.2-Adapted-COVID-19-Vaccine.webp https://thepharmadata.com/european-commission-grants-approval-to-modernas-rsv-vaccine-mresvia/ 2024-08-24T11:19:31+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/European-Commission-Grants-Approval-to-Modernas-RSV-Vaccine-mRESVIA.webp https://thepharmadata.com/leqembi-lecanemab-approved-for-early-alzheimers-disease-treatment-in-great-britain/ 2024-08-24T11:39:40+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Leqembi-lecanemab-Approved-for-Early-Alzheimers-Disease-Treatment-in-Great-Britain.webp https://thepharmadata.com/gsks-b7-h3-antibody-drug-conjugate-receives-fda-breakthrough-designation-for-small-cell-lung-cancer/ 2024-08-24T11:47:36+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/GSKs-B7-H3-Antibody-Drug-Conjugate-Receives-FDA-Breakthrough-Designation-for-Small-Cell-Lung-Cancer.webp https://thepharmadata.com/aetna-contributes-100000-to-support-safer-foundation/ 2024-08-24T11:55:24+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Aetna-Contributes-100000-to-Support-Safer-Foundation.webp https://thepharmadata.com/marias-journey-navigating-life-with-a-rare-liver-disease/ 2024-08-24T12:01:01+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Marias-Journey-Navigating-Life-with-a-Rare-Liver-Disease.webp https://thepharmadata.com/advi-health-partners-with-health-analytic-research-for-acquisition/ 2024-08-24T12:07:01+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/ADVI-Health-Partners-with-Health-Analytic-Research-for-Acquisition.webp https://thepharmadata.com/invenras-inv724-gets-fda-rare-pediatric-disease-and-orphan-drug-designations-for-neuroblastoma/ 2024-08-24T12:18:03+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Invenras-INV724-Gets-FDA-Rare-Pediatric-Disease-and-Orphan-Drug-Designations-for-Neuroblastoma.webp https://thepharmadata.com/bristol-myers-squibb-to-showcase-cardiovascular-portfolio-data-at-the-european-society-of-cardiology-congress-2024/ 2024-08-27T10:01:14+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Bristol-Myers-Squibb-to-Showcase-Cardiovascular-Portfolio-Data-at-the-European-Society-of-Cardiology-Congress-2024.webp https://thepharmadata.com/new-dupixent-and-itepekimab-data-at-ers-showcases-respiratory-innovation-and-leadership/ 2024-08-27T10:11:19+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/New-Dupixent-and-Itepekimab-Data-at-ERS-Showcases-Respiratory-Innovation-and-Leadership.webp https://thepharmadata.com/ordspono-odronextamab-eu-approval-for-treating-relapsed-refractory-lymphomas/ 2024-08-27T10:18:35+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Ordspono-odronextamab-EU-Approval-for-Treating-RelapsedRefractory-Lymphomas.webp https://thepharmadata.com/delcath-systems-reports-promising-study-on-repeated-liver-chemosaturation/ 2024-08-27T10:44:48+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Delcath-Systems-Reports-Promising-Study-on-Repeated-Liver-Chemosaturation.webp https://thepharmadata.com/2024-2031-analysis-of-pharmaceutical-processing-and-packaging-equipment-market-size-share-forecasts-and-trends/ 2024-08-27T10:53:34+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/2024-2031-Analysis-of-Pharmaceutical-Processing-and-Packaging-Equipment-Market-Size-Share-Forecasts-and-Trends.webp https://thepharmadata.com/quantum-si-announces-new-executive-team-to-drive-companys-growth-in-proteomics/ 2024-08-28T10:07:57+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Quantum-Si-Announces-New-Executive-Team-to-Drive-Companys-Growth-in-Proteomics.webp https://thepharmadata.com/correction-omny-health-expands-glp-1-patient-network-to-over-600000-for-enhanced-clinical-research/ 2024-08-28T10:21:33+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Correction-OMNY-Health-Expands-GLP-1-Patient-Network-to-Over-600000-for-Enhanced-Clinical-Research.webp https://thepharmadata.com/avanzati-bioscience-secures-eu-approval-for-orphan-drug-akantior/ 2024-08-28T10:28:11+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Avanzati-Bioscience-Secures-EU-Approval-for-Orphan-Drug-AKANTIOR.webp https://thepharmadata.com/medimpact-broadens-access-to-two-humira-biosimilars-for-new-patients/ 2024-08-28T10:34:46+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/MedImpact-Broadens-Access-to-Two-Humira-Biosimilars-for-New-Patients.webp https://thepharmadata.com/hinge-health-and-midi-health-collaborate-to-offer-comprehensive-menopause-care/ 2024-08-28T10:42:00+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Hinge-Health-and-Midi-Health-Collaborate-to-Offer-Comprehensive-Menopause-Care.webp https://thepharmadata.com/roches-piasky-receives-eu-approval-as-the-first-monthly-subcutaneous-treatment-for-pnh-patients/ 2024-08-31T10:10:06+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Roches-PiaSky-Receives-EU-Approval-as-the-First-Monthly-Subcutaneous-Treatment-for-PNH-Patients.webp https://thepharmadata.com/get-your-updated-flu-and-covid-19-vaccinations-now-at-cvs-pharmacy-and-minuteclinic/ 2024-08-31T10:17:47+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Get-Your-Updated-Flu-and-COVID-19-Vaccinations-Now-at-CVS-Pharmacy-and-MinuteClinic.webp https://thepharmadata.com/eu-approves-expanded-use-of-gsks-arexvy-rsv-vaccine-for-at-risk-adults-aged-50-59/ 2024-08-31T10:24:21+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/EU-Approves-Expanded-Use-of-GSKs-Arexvy-RSV-Vaccine-for-At-Risk-Adults-Aged-50-59.webp https://thepharmadata.com/merck-begins-phase-iii-study-with-first-patient-dosed-for-oral-cladribine-in-gmg/ 2024-08-31T10:44:05+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Merck-Begins-Phase-III-Study-with-First-Patient-Dosed-for-Oral-Cladribine-in-gMG.webp https://thepharmadata.com/japan-approves-alecensa-for-adjuvant-treatment-of-alk-positive-early-stage-non-small-cell-lung-cancer/ 2024-08-31T10:51:49+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Japan-Approves-Alecensa-for-Adjuvant-Treatment-of-ALK-Positive-Early-Stage-Non-Small-Cell-Lung-Cancer.webp https://thepharmadata.com/marketing-and-future-prospects-for-the-secondary-hyperparathyroidism-drug-oxarol-for-injection-in-japan/ 2024-08-31T11:01:15+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Marketing-and-Future-Prospects-for-the-Secondary-Hyperparathyroidism-Drug-OXAROL-for-Injection-in-Japan.webp https://thepharmadata.com/moderna-unveils-nationwide-campaign-to-boost-covid-19-vaccination-rates/ 2024-08-31T11:08:05+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Moderna-Unveils-Nationwide-Campaign-to-Boost-COVID-19-Vaccination-Rates.webp https://thepharmadata.com/european-commission-approves-astellas-padcev-with-keytruda-for-advanced-urothelial-cancer/ 2024-08-31T11:15:38+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/European-Commission-Approves-Astellas-PADCEV-with-KEYTRUDA-for-Advanced-Urothelial-Cancer.webp https://thepharmadata.com/scaleready-awards-inaugural-g-rex-grant-to-stanford-medicine-laboratory/ 2024-08-31T11:41:30+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/ScaleReady-Awards-Inaugural-G-Rex-Grant-to-Stanford-Medicine-Laboratory.webp https://thepharmadata.com/neurocrine-biosciences-announces-positive-phase-2-results-for-nbi-1117568-in-adults-with-schizophrenia/ 2024-08-31T11:49:43+05:30 https://thepharmadata.com/wp-content/uploads/2024/08/Neurocrine-Biosciences-Announces-Positive-Phase-2-Results-for-NBI-1117568-in-Adults-with-Schizophrenia.webp